A major review reports no clinically meaningful benefit from antiamyloid therapies for Alzheimer’s disease, but some experts argue the analysis is skewed because it included failed drug trials.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/no-clinical-benefit-antiamyloids-alzheimers-review-concludes-2026a1000c32?src=rss
Author :
Publish date : 2026-04-17 12:08:00
Copyright for syndicated content belongs to the linked Source.